VARIATIONS IN THE NATURAL COURSE OF ELEVATED PLASMA HOMOCYSTEINE LEVEL FOLLOWING RETINAL VEIN OCCLUSION AT PRESENTATION.
Kapil Deb Lahiri*, Arunava Kundu, Bholanath Maji, Jayanta Dutta and Himadri Datta
ABSTRACT
Purpose: No study has done yet to see the natural course of high
homocysteine (HHcys) level following retinal vein occlusion (RVO).
Hence our study tried to find out level of Hcys after 1 month of follow
up among the RVO with HHcys at presentation. Material & Methods:
A total of 37 patients with HHcys on the 2nd day of presentation in
RVO, were reevaluated for fasting plasma Hcys levels on 30th day in
their respective follow up in one year prospective case-control study.
No intervention was done to reduce the HHcys during this period.
Results: Hcys levels were increased significantly in the patients with
RVO (mean total Hcys, 18.16 ± 4.73 μmol/L) as opposed to the control
subjects (mean total Hcys, 11.05 ± 2.21 μmol/L; P < 0.001) on 2nd day of presentation. One
month follow up Hcys estimation revealed 22 patients with HHcys (mean total Hcys, 17.16 ±
4.13 μmol/L) and 15 patients with normal Hcys level (mean total Hcys, 11.76 ± 2.93 μmol/L).
Conclusions: Elevated Hcys is not only a risk factor for RVO but also a marker of acute
retinal vein occlusion hence routine therapy of Hcys lowering agents should be done
judiciously in retinal vein occusion patients at presentation.
Keywords: Homocysteine (Hcys), Hyperhomocysteinemia (HHcys), Retinal vein occlusion (RVO).
[Full Text Article]